NCT00476164View on ClinicalTrials.gov

Study of Rituximab to Treat Chronic Renal Transplant Rejection

PHASE4CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

May 31, 2015

Study Completion Date

April 30, 2017

Conditions
Kidney TransplantationGraft RejectionImmunosuppression
Interventions
DRUG

Rituximab

2 doses of 1g 14 days apart

OTHER

Control arm

Continue of optimised oral immunosuppression

Trial Locations (11)

B15 2LN

University Hospital Birmingham, Birmingham

CT1 3NG

East Kent Hospitals University NHS Foundation Trust, Canterbury

CF14 4XW

Univeristy Hospital of Wales, Cardiff

SM5 1AA

Epsom & St Helier University Hospitals Trust, Carshalton

G11 6NT

Western Infirmary, Glasgow

HU3 2JZ

Hull Royal Infirmary, Hull

LS9 7TF

St Jame's University Hospital, Leeds

NW3 2PF

The Royal Free Hospital, London

SE 19RT

King's College London, Guy's Hospital, London

W12 0NN

Imperial College London and West London Renal & Transplantation Centre, London

M13 9WL

Manchester Royal Infirmary, Manchester

Sponsors

Collaborators (1)

Medical Research Council
All Listed Sponsors
collaborator

Medical Research Council

OTHER_GOV

collaborator

Roche Pharma AG

INDUSTRY

lead

King's College London

OTHER